首页> 外国专利> crystalline form of (s) - 2 - (6 - chloro - 7 - methyl) - 1h benzo d 2 - (2 -) - 2 - methylpyrrolidin 1 yl) 5 - methoxy - 2 - (2 - 2 - (3 - triazol) phenyl) methanone and use the latter as antagonists of the receptors for the orexine

crystalline form of (s) - 2 - (6 - chloro - 7 - methyl) - 1h benzo d 2 - (2 -) - 2 - methylpyrrolidin 1 yl) 5 - methoxy - 2 - (2 - 2 - (3 - triazol) phenyl) methanone and use the latter as antagonists of the receptors for the orexine

机译:(s)-2-(6-氯-7-甲基)-1h苯并[d] [[2--(2--)-2-甲基吡咯烷酮1基)5-甲氧基-2-(2-[[ 2-(3-三唑)苯基)甲酮,并用作后者的Orexine受体拮抗剂

摘要

The invention relates to the crystalline form of () s - (() 2 - (() 6-chloro-7-methyl-1h-benzo [(d) imidazol-2-yl-2-methylpyrrolidine-1-medicinal base () 5-methylpyrrolidine-2 - (() 2h-1, 2, 3-triazol-2-yl) methane, the preparation method, the pharmaceutical composition containing the crystalline form, and the preparation method From this crystalline form and its use as a drug, especially as an antagonist of the orexin receptor.
机译:本发明涉及()s-(()2-(()6-氯-7-甲基-1h-苯并[(d)咪唑-2-基-2-甲基吡咯烷-1-药用碱( )5-甲基吡咯烷-2-(()2h-1,2,3-三唑-2-基)甲烷,其制备方法,含有该晶型的药物组合物以及制备方法由该晶型及其用途一种药物,特别是作为orexin受体的拮抗剂

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号